Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

CEO resigns as Eli Lilly (LLY) dominates the weight loss drug market and compounders threaten the company's financial outlook ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Traders should observe LLY’s price action for signals that may influence short-term crypto volatility ... particularly related to pricing pressures and regulatory scrutiny surrounding weight-loss ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

The discontinuation rate due to side effects was 6.1% for Zepbound and 8% for Wegovy ... Trump cited a “Most Favored Nation ...

While many pharma and biotech companies developing drugs to treat Alzheimer's disease are targeting amyloid beta plaque, Eli ...

Novo Nordisk has replaced CEO Lars Fruergaard Jorgensen amid competitive pressures in the obesity drug market. His exit comes ...

The discontinuation rate due to side effects was 6.1% for Zepbound and 8% for Wegovy ... Trump cited a “Most Favored Nation Policy” in a Truth Social post, saying it would align US drug prices with ...

Eli Lilly (LLY) shares take a dip after Politico reports that President Trump will sign a new executive order around drug ...